These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6487989)

  • 1. Activity of the newer quinolones against Chlamydia trachomatis.
    Van Roosbroeck RJ; Provinciael DR; Van Caekenberghe DL
    Br J Vener Dis; 1984 Oct; 60(5):350. PubMed ID: 6487989
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of antimicrobials against Chlamydia trachomatis in vitro.
    Ridgway GL; Oriel JD
    J Antimicrob Chemother; 1979 Jul; 5(4):483-4. PubMed ID: 489497
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of ofloxacin against Chlamydia trachomatis.
    Møller BR; Evans R; Kaspersen P; From E
    Drugs; 1987; 34 Suppl 1():181-3. PubMed ID: 3481321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activity of a new quinoline derivative against Chlamydia trachomatis].
    Mitsui Y; Higashitsutsumi M
    Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
    [No Abstract]   [Full Text] [Related]  

  • 5. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.
    Ridgway GL; Owen JM; Oriel JD
    Br J Vener Dis; 1978 Apr; 54(2):103-6. PubMed ID: 638716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro, activity of a new macrolide (RU 28965) against Chlamydia trachomatis and Ureaplasma urealyticum].
    Sambri V; Rumpianesi F; Franchi L; Cevenini R
    G Ital Chemioter; 1985; 32(1):175-6. PubMed ID: 3830774
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods of studying the sensitivity of Chlamydia trachomatis to antibiotics].
    Laurans G; Orfila J; Haider F
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1982; (2-3):93-106. PubMed ID: 7187965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the in vitro activity of various antibiotics against Chlamydia trachomatis by indirect immunoperoxidase method].
    Bannai H; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1986 Oct; 60(10):1140-6. PubMed ID: 3100692
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of thirteen beta-lactam antibiotics against Chlamydia trachomatis.
    Muytjens HL; Heessen FW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):520-1. PubMed ID: 7137988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of fifteen Chlamydia trachomatis strains isolated in Greece.
    Mentis AF; Tzouvelekis LS; Mavrommati L
    J Antimicrob Chemother; 1989 Jul; 24(1):94. PubMed ID: 2777733
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.
    Cevenini R; Sambri V; La Placa M
    Eur J Clin Microbiol; 1986 Oct; 5(5):598-600. PubMed ID: 3536506
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.
    Notomi T; Ikeda Y; Nagayama A
    Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of ++clarithromycin against mycoplasma and chlamydia].
    Franzoso G; Cusinato R; Tonin EA; Meloni GA
    G Ital Chemioter; 1991; 38(1-3):159-61. PubMed ID: 1365578
    [No Abstract]   [Full Text] [Related]  

  • 15. A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.
    Ridgway GL; Owen JM; Oriel JD
    J Antimicrob Chemother; 1976 Mar; 2(1):71-6. PubMed ID: 931835
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro sensitivity of Chlamydiae to antibiotics].
    Dailloux M; Ottemer C; Albert H; Weber M
    Pathol Biol (Paris); 1990 May; 38(5):426-30. PubMed ID: 2195451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis.
    Futakuchi N; Nakatani M; Takahata M; Mitsuyama J
    J Infect Chemother; 2012 Aug; 18(4):428-35. PubMed ID: 22113367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro.
    Yamazaki T; Kishimoto T; Shiga S; Sato K; Hagiwara T; Inoue M; Sasaki N; Ouchi K; Hara Y
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2501-3. PubMed ID: 15917555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.